Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Page Path

HOME
ARTICLE CATEGORY
Review

Review

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 28232 Download: 416 Citations: 18

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol. 2017;23(1):13-21. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0110

View: 14094 Download: 802 Citations: 50

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 16953 Download: 590 Citations: 137

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 10658 Download: 362 Citations: 26

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 12364 Download: 535 Citations: 46

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0056

View: 13509 Download: 755 Citations: 53

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 14895 Download: 532 Citations: 49

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 12664 Download: 382 Citations: 67

Liver transplantation for advanced hepatocellular carcinoma

Hae Won Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2016;22(3):309-318. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0042

View: 11779 Download: 264 Citations: 21

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 16154 Download: 641 Citations: 80

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol. 2016;22(2):212-218. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0026

View: 12470 Download: 282 Citations: 49

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 17541 Download: 608 Citations: 36

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 25352 Download: 204 Citations: 53

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 23455 Download: 256 Citations: 133

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 19230 Download: 539 Citations: 201

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 13881 Download: 340 Citations: 29

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 7746 Download: 193 Citations: 24

Imaging findings of mimickers of hepatocellular carcinoma

Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang

Clin Mol Hepatol. 2015;21(4):326-343. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.326

View: 39805 Download: 957 Citations: 23

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 11644 Download: 218 Citations: 68

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 13271 Download: 370 Citations: 77

Managing alcoholic liver disease

Vijay H. Shah

Clin Mol Hepatol. 2015;21(3):212-219. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.212

View: 8448 Download: 253 Citations: 14

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9128 Download: 124 Citations: 26

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 8262 Download: 191 Citations: 10

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 9797 Download: 141 Citations: 30

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens, Yujin Hoshida

Clin Mol Hepatol. 2015;21(2):105-114. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.105

View: 17869 Download: 322 Citations: 102

The cost of liver disease in Korea: methodology, data, and evidence

Wankyo Chung

Clin Mol Hepatol. 2015;21(1):14-21. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.14

View: 7391 Download: 101 Citations: 17

Clinical implications of advances in liver regeneration

Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi

Clin Mol Hepatol. 2015;21(1):7-13. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.7

View: 10558 Download: 213 Citations: 42

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 7974 Download: 138 Citations: 17

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 7971 Download: 77 Citations: 3

Cost-of-illness studies: concepts, scopes, and methods

Changik Jo

Clin Mol Hepatol. 2014;20(4):327-337. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.327

View: 23423 Download: 615 Citations: 336

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

06 Days

*Last 12 months

Viewed By 5423	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4830	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 4194	MAFLD: How is it different from NAFLD?
Viewed By 3974	A decade of liver organoids: Advances in disease modeling
Viewed By 2987	Management of refractory ascites

Cited By 128	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 77	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 57	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 55	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 51	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma